Nasal administration of the neuroprotective candidate NeuroEPO to healthy volunteers: a randomized, parallel, open-label safety study

Other

Abstract: Delivery of therapeutic agents as erythropoietin (EPO) into Central Nervous System through intranasa

Palabras claves:

Autores:

Ivón Howland-Álvarez

Fuentes:

google